CRISPR Therapeutics (CRSP) PT Raised to $82 at Needham
Tweet
Share
E-mailGet Alerts CRSP Hot Sheet
Price: $52.97 -2.41%
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
19 Buy, 14 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
Needham analyst Gil Blum raised the price target on CRISPR Therapeutics (NASDAQ: CRSP) to $82.00 (from $80.00) while maintaining a Buy rating.
You May Also Be Interested In
- Marvell (MRVL) PT Raised to $225 at TD Cowen
- Home Depot (HD) PT Lowered to $407 at BofA Securities
- Amgen (AMGN) PT Raised to $400 at Cantor Fitzgerald on Higher Sales Estimates
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
